In breast cancer cell lines, CCN6 overexpression inhibits cell growth and invasiveness, while CCN6 induces a epithelial to mesenchymal transition (EMT) and reduces tumor-initiating cells (TIC), which is mediated by the downregulation of Slug and inhibition of the Notch1 signaling pathway30,31. Here, NOTCH1 is linked to neoplasm.